APA

Patel A., Tannock I. F., Srivastava P., Biswas B., Gupta V. G., Batra A., Bhethanabhotla S., Pramanik R., Mahindru S., Tilak T., Das C. K. & Mehta P. (20210728). Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets. : JCO global oncology.

Chicago

Patel Amol, Tannock Ian F, Srivastava Priyanka, Biswas Bivas, Gupta Vineet Govinda, Batra Atul, Bhethanabhotla Sainath, Pramanik Raja, Mahindru Shubh, Tilak Tvsvgk, Das Chandan Krishna and Mehta Prashant. 20210728. Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets. : JCO global oncology.

Harvard

Patel A., Tannock I. F., Srivastava P., Biswas B., Gupta V. G., Batra A., Bhethanabhotla S., Pramanik R., Mahindru S., Tilak T., Das C. K. and Mehta P. (20210728). Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets. : JCO global oncology.

MLA

Patel Amol, Tannock Ian F, Srivastava Priyanka, Biswas Bivas, Gupta Vineet Govinda, Batra Atul, Bhethanabhotla Sainath, Pramanik Raja, Mahindru Shubh, Tilak Tvsvgk, Das Chandan Krishna and Mehta Prashant. Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets. : JCO global oncology. 20210728.